Hikma Pharmaceuticals Executive and Leadership Team

Ala'a Habboub, the Chief Financial Officer (Jordan) at Hikma Pharmaceuticals, directs financial strategy and operations within the Jordanian market. This leadership role involves managing budgets, forecasting financial performance, and ensuring fiscal compliance for the company's activities in the region. Overseeing all financial planning and analysis, Habboub drives profitability and resource allocation. The Chief Financial Officer (Jordan) collaborates with regional leadership to align financial objectives with business growth targets, ensuring sustainable economic health for Hikma Pharmaceuticals' operations in Jordan. Ala'a Habboub's oversight extends to risk management and the implementation of robust financial controls, safeguarding company assets and optimizing financial performance across all Jordanian ventures.

Areb Kurdi, the Acting Chief Financial Officer at Hikma Pharmaceuticals, provides critical financial leadership and oversight during a transitional period. This role encompasses managing the company's financial health, including budgeting, financial reporting, and capital allocation across global operations. Kurdi ensures adherence to financial regulations and drives strategic financial planning to support Hikma Pharmaceuticals' growth objectives. The Acting Chief Financial Officer collaborates closely with the executive team and the board to present financial performance and guide investment decisions. Areb Kurdi's focus remains on maintaining financial stability and integrity, supporting the company's mission to improve patient access to high-quality medicines worldwide.

Tareq Darwazeh, the Chief Operating Officer (MENA Region) at Hikma Pharmaceuticals, spearheads operational excellence across the Middle East and North Africa. This executive directs the execution of business strategies, ensuring efficient production, supply chain management, and distribution of pharmaceutical products throughout the MENA territory. Darwazeh's responsibilities include optimizing operational workflows, enhancing manufacturing capabilities, and driving market penetration within the region. The Chief Operating Officer (MENA Region) fosters cross-functional collaboration to achieve key performance indicators and maintain high standards of product quality and accessibility. Tareq Darwazeh's leadership ensures that Hikma Pharmaceuticals effectively meets the healthcare needs of the MENA population through streamlined and effective operations.

Bassam Kanaan, the Executive VP, Corporate Development Mergers & Acquisitions at Hikma Pharmaceuticals, drives strategic growth through the identification and execution of key acquisitions and partnerships. This executive leads the evaluation of potential business development opportunities, assessing market trends and competitive landscapes to inform strategic decisions. Kanaan oversees the entire M&A process, from initial due diligence to deal closure, ensuring alignment with Hikma Pharmaceuticals' long-term vision. The Executive VP, Corporate Development Mergers & Acquisitions plays a pivotal role in expanding the company's global footprint and product portfolio. Bassam Kanaan's expertise is crucial in shaping the future direction of Hikma Pharmaceuticals through targeted corporate development initiatives.

Chawki Sabri, the Finnance at Hikma Pharmaceuticals, contributes to the company's financial operations and strategic initiatives. This role involves supporting financial planning, analysis, and reporting to ensure the fiscal health of the organization. Sabri works to optimize financial processes and contribute to the effective management of company resources. The Finnance collaborates with various departments to align financial activities with Hikma Pharmaceuticals' overarching business goals. Chawki Sabri's efforts support the company's commitment to providing essential medicines and driving sustainable growth in the pharmaceutical sector.